Aspen Pharmacare ROA 2017-2023 | APNHY

Current and historical return on assets (ROA) values for Aspen Pharmacare (APNHY) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Aspen Pharmacare ROA - Return on Assets Historical Data
Date TTM Net Income Total Assets Return on Assets
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $5.172B $2.296B
Aspen Pharmacare Holdings Limited provide specialty, branded and generic pharmaceuticals for acute and chronic conditions. It operates primarily in Sub-Saharan Africa, Latin America, South East Asia and Eastern Europe. Aspen Pharmacare Holdings Limited is headquartered in Durban, South Africa.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $14.776B 5.34
Dr Reddy's Laboratories (RDY) India $11.900B 18.82
BridgeBio Pharma (BBIO) United States $4.392B 0.00
Bausch Health Cos (BHC) Canada $3.164B 2.47
Amphastar Pharmaceuticals (AMPH) United States $1.957B 13.40
Supernus Pharmaceuticals (SUPN) United States $1.587B 0.00
Taysha Gene Therapies (TSHA) United States $0.458B 0.00
Generation Bio (GBIO) United States $0.198B 0.00
Assembly Biosciences (ASMB) United States $0.071B 0.00
Personalis (PSNL) United States $0.061B 0.00
Acasti Pharma (ACST) Canada $0.030B 0.00
Sol-Gel Technologies (SLGL) Israel $0.024B 0.00
Evoke Pharma (EVOK) United States $0.005B 0.00
Teligent (TLGT) United States $0.000B 0.00